Clinical Trial Update: Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating immunogenicity and persistence of Hepatitis B vaccination in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis Vaccine Response in Hiv-infected Individuals

Snippet

Sponsor: Shanxi Medical University | Conditions: Hepatitis B Vaccine | Phase 4 | Status: UNKNOWN